Cargando…

Corrigendum: Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment

Detalles Bibliográficos
Autores principales:	Dutta, Sara, Chang, Kelly C., Beattie, Kylie A., Sheng, Jiansong, Tran, Phu N., Wu, Wendy W., Wu, Min, Strauss, David G., Colatsky, Thomas, Li, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723676/ https://www.ncbi.nlm.nih.gov/pubmed/29230183 http://dx.doi.org/10.3389/fphys.2017.01025

Ejemplares similares

Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
por: Dutta, Sara, et al.
Publicado: (2017)

Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in Silico Proarrhythmia Risk Assessment
por: Chang, Kelly C., et al.
Publicado: (2017)

Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
por: Li, Zhihua, et al.
Publicado: (2018)

Quantitative Systems Pharmacology Models for a New International Cardiac Safety Regulatory Paradigm: An Overview of the Comprehensive In Vitro Proarrhythmia Assay In Silico Modeling Approach
por: Li, Zhihua, et al.
Publicado: (2019)

Proarrhythmia in the p.Met207Val PITX2c-Linked Familial Atrial Fibrillation-Insights From Modeling
por: Bai, Jieyun, et al.
Publicado: (2019)

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy
por: Li, Zhihua, et al.
Publicado: (2019)

Translational Models and Tools to Reduce Clinical Trials and Improve Regulatory Decision Making for QTc and Proarrhythmia Risk (ICH E14/S7B Updates)
por: Strauss, David G., et al.
Publicado: (2021)

Uncertainty assessment of proarrhythmia predictions derived from multi-level in silico models
por: Kopańska, Karolina, et al.
Publicado: (2023)

Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction
por: Trovato, Cristian, et al.
Publicado: (2022)

Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19
por: Delaunois, Annie, et al.
Publicado: (2021)

Proarrhythmia Induced by Propafenone: What is the Mechanism?
por: Femenia, Francisco, et al.
Publicado: (2010)

Transgenic Rabbit Models in Proarrhythmia Research
por: Baczkó, István, et al.
Publicado: (2020)

Proarrhythmia and Oncotherapy: So Much To Be Done!
por: Kovacs, Richard J.
Publicado: (2021)

Automated Algorithm for J-T(peak) and T(peak)-T(end) Assessment of Drug-Induced Proarrhythmia Risk
por: Johannesen, Lars, et al.
Publicado: (2016)

Proarrhythmia in a Patient With Heart Failure on Therapy With Amiodarone
por: Semerdzhieva, Niya E, et al.
Publicado: (2021)

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia
por: Uddin, Muhammad Erfan, et al.
Publicado: (2022)

Early Drug Discovery Prediction of Proarrhythmia Potential and Its Covariates
por: Polak, Sebastian, et al.
Publicado: (2015)

Assessment of drug-induced proarrhythmias due to pilsicainide in patients with atrial tachyarrhythmias
por: Koike, Hideki, et al.
Publicado: (2016)

Necessity to evaluate PI3K/Akt signalling pathway in proarrhythmia
por: Ezeani, Martin, et al.
Publicado: (2017)

The Role of the Food and Drug Administration in Drug Development: On the Subject of Proarrhythmia Risk
por: Thind, Munveer, et al.
Publicado: (2020)

In silico Prediction of Sex-Based Differences in Human Susceptibility to Cardiac Ventricular Tachyarrhythmias
por: Yang, Pei-Chi, et al.
Publicado: (2012)

In silico Optimization of Left Atrial Appendage Occluder Implantation Using Interactive and Modeling Tools
por: Aguado, Ainhoa M., et al.
Publicado: (2019)

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system
por: Wang, Feifei, et al.
Publicado: (2023)

Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring
por: Simoons, Mirjam, et al.
Publicado: (2018)

Right ventricular lead proarrhythmia: A novel intervention for an under-recognized phenomenon
por: Hayase, Justin, et al.
Publicado: (2017)

Corrigendum: Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation
por: Bazzazi, Hojjat, et al.
Publicado: (2017)

Corrigendum: Application of Blood Flow Restriction to Optimize Exercise Countermeasures for Human Space Flight
por: Behringer, Michael, et al.
Publicado: (2019)

Automatic Optimization of an in Silico Model of Human iPSC Derived Cardiomyocytes Recapitulating Calcium Handling Abnormalities
por: Paci, Michelangelo, et al.
Publicado: (2018)

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

Corrigendum: FVB/NJ Mice Are a Useful Model for Examining Cardiac Adaptations to Treadmill Exercise
por: Gibb, Andrew A., et al.
Publicado: (2017)

Effect of hydroxychloroquine on proarrhythmia risk assessment using human iPSC-derived cardiomyocytes
por: Yanagida, Shota, et al.
Publicado: (2021)

CaMKII Serine 280 O-GlcNAcylation Links Diabetic Hyperglycemia to Proarrhythmia
por: Hegyi, Bence, et al.
Publicado: (2021)

Corrigendum: Effect of Black Tea Extract and Thearubigins on Osteoporosis in Rats and Osteoclast Formation in vitro
por: Liang, Qingqing, et al.
Publicado: (2020)

Corrigendum: Lactate and Myocardiac Energy Metabolism
por: Dong, Shuohui, et al.
Publicado: (2022)

Integration of in vitro and in silico Models Using Bayesian Optimization With an Application to Stochastic Modeling of Mesenchymal 3D Cell Migration
por: Merino-Casallo, Francisco, et al.
Publicado: (2018)

Corrigendum: Phenotypic variability in iPSC-induced cardiomyocytes and cardiac fibroblasts carrying diverse LMNA mutations
por: Yang, Jiajia, et al.
Publicado: (2022)

Corrigendum: The Role of Krüppel-like Factor 4 in Renal Fibrosis
por: Ke, Ben, et al.
Publicado: (2016)

Corrigendum: Comparative Analysis of Lower Genital Tract Microbiome Between PCOS and Healthy Women
por: Tu, Yaoyao, et al.
Publicado: (2021)

SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19
por: Mezache, Louisa, et al.
Publicado: (2023)

Recruitment of the cardiac conduction system for optimal resynchronization therapy in failing heart
por: Chen, Zhongli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1423gvufohriibiiso5j9fhriu